Forte Biosciences appoints David Gryska to board; Patricia Walker resigns

Forte Biosciences, Inc.

David Gryska appointed as Class II director effective January 10, 2023; serves on Audit Committee.
Gryska is former CFO/Exec VP of Incyte and Celgene; receives 50,000 stock option vesting over 3 years.
Patricia Walker resigned from board and all committees effective January 6, 2023; no disagreement cited.
Gryska will receive $40,000/year as director plus $8,000/year for Audit Committee service.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

David Gryska

Director

FBRX · Forte Biosciences, Inc.

Effective: 2023-01-10
Filed: January 12, 2023, 6:59 PM ET

On January 10, 2023, the Board of Directors (the “Board) of the Company, upon recommendation of the Nominating and Governance Committee of the Board, appointed David Gryska, M.B.A. to the Board to fill a vacancy on the Board, effective January 10, 2023.

Departed

Patricia Walker

Director

FBRX · Forte Biosciences, Inc.

Effective: 2023-01-06
Filed: January 12, 2023, 6:59 PM ET

On January 6, 2023, Patricia Walker, M.D., Ph.D. notified Forte Biosciences, Inc. (the “Company”) of her resignation as a member of the Board of Directors (the “Board”) of the Company and from all committees of the Board on which she served, in each case effective as of January 6, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

David Gryska was appointed as Director at Forte Biosciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

On January 10, 2023, the Board of Directors (the “Board) of the Company, upon recommendation of the Nominating and Governance Committee of the Board, appointed David Gryska, M.B.A. to the Board to fill a vacancy on the Board, effective January 10, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Patricia Walker resigned as Director at Forte Biosciences, Inc..

Action: resigned
Role: Director

Exact text from the filing

On January 6, 2023, Patricia Walker, M.D., Ph.D. notified Forte Biosciences, Inc. (the “Company”) of her resignation as a member of the Board of Directors (the “Board”) of the Company and from all committees of the Board on which she served, in each case effective as of January 6, 2023.

View on SEC.gov

Forte Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-007190

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.